AAAAAA

   
Results: 1-21 |
Results: 21
VITAMIN SUPPLEMENTATION REDUCES BLOOD HOMOCYSTEINE LEVELS - A CONTROLLED TRIAL IN PATIENTS WITH VENOUS THROMBOSIS AND HEALTHY-VOLUNTEERS
Authors: DENHEIJER M BROUWER IA BOS GMJ BLOM HJ VANDERPUT NMJ SPAANS AP ROSENDAAL FR THOMAS CMG HAAK HL WIJERMANS PW GERRITS WBJ
Citation: M. Denheijer et al., VITAMIN SUPPLEMENTATION REDUCES BLOOD HOMOCYSTEINE LEVELS - A CONTROLLED TRIAL IN PATIENTS WITH VENOUS THROMBOSIS AND HEALTHY-VOLUNTEERS, Arteriosclerosis, thrombosis, and vascular biology, 18(3), 1998, pp. 356-361
LOWERING BLOOD HOMOCYSTEINE WITH FOLIC-ACID BASED SUPPLEMENTS - METAANALYSIS OF RANDOMIZED TRIALS
Authors: BRATTSTROM L LANDGREN F ISRAELSSON B LINDGREN A HULTBERG B ANDERSSON A CUSKELLY G MCNULTY H STRAIN SS MCPARTLIN J WEIR DG SCOTT JM DENHEIJER M BROUWER IA BLOM HJ BOS GMJ SPAANS A ROSENDAAL FR THOMAS CMG HAAK HL WIJERMANS PW GERRITS WBJ NAURATH HJ JOOSTEN E RIEZLER R STABLER SP ALLEN RH LINDENBAUM J PIETRZIK K PRINZLANGENOHL R DIERKES J SALTZMAN E MASON JB JACQUES P SELHUB J SALEM D SCHAEFER E ROSENBERG IH UBBINK J VANDERMERE A VERMACK WJH DELPORT R BECKER PJ POTGIETER HC WOODSIDE JV YARNELL JWG MCMASTER D YOUNG IS MCCRUM EE PATTERSON SS GEY KF EVANS AE CLARKE R APPLEBY P HARDING P SHERLIKER P COLLINS R FROST C LEROY V
Citation: L. Brattstrom et al., LOWERING BLOOD HOMOCYSTEINE WITH FOLIC-ACID BASED SUPPLEMENTS - METAANALYSIS OF RANDOMIZED TRIALS, BMJ. British medical journal, 316(7135), 1998, pp. 894-898
A CASE OF NON-BETA-GLOBIN GENE LINKED BETA-THALASSEMIA IN A DUTCH FAMILY WITH 2 ADDITIONAL ALPHA-GENE DEFECTS - THE COMMON -ALPHA(3-CENTER-DOT-7) DELETION AND THE RARE IVS1-116 (A-]G) ACCEPTOR SPLICE-SITE MUTATION
Authors: GIORDANO PC HARTEVELD CL HAAK HL BATELAAN D VANDELFT P PLUG RJ EMONTS M ZANARDINI R BERNINI LF
Citation: Pc. Giordano et al., A CASE OF NON-BETA-GLOBIN GENE LINKED BETA-THALASSEMIA IN A DUTCH FAMILY WITH 2 ADDITIONAL ALPHA-GENE DEFECTS - THE COMMON -ALPHA(3-CENTER-DOT-7) DELETION AND THE RARE IVS1-116 (A-]G) ACCEPTOR SPLICE-SITE MUTATION, British Journal of Haematology, 103(2), 1998, pp. 370-376
INTENSIVE POSTREMISSION CHEMOTHERAPY WITHOUT MAINTENANCE THERAPY IN ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: DEKKER AW VANTVEER MB SIZOO W HAAK HL VANDERLELIE J OSSENKOPPELE G HUIJGENS PC SCHOUTEN HC SONNEVELD P WILLEMZE R VERDONCK LF VANPUTTEN WLJ LOWENBERG B
Citation: Aw. Dekker et al., INTENSIVE POSTREMISSION CHEMOTHERAPY WITHOUT MAINTENANCE THERAPY IN ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of clinical oncology, 15(2), 1997, pp. 476-482
PROSPECTIVE RANDOMIZED PLACEBO-CONTROLLED STUDY OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR WITHOUT STEM-CELL TRANSPLANTATION AFTERHIGH-DOSE MELPHALAN IN PATIENTS WITH MULTIPLE-MYELOMA
Authors: MOREAU P FIERE D BEZWODA WR FACON T ATTAL M LAPORTE JP COLOMBAT P HAAK HL MONCONDUIT M LOCKHORST H GIRAULT D HAROUSSEAU JL
Citation: P. Moreau et al., PROSPECTIVE RANDOMIZED PLACEBO-CONTROLLED STUDY OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR WITHOUT STEM-CELL TRANSPLANTATION AFTERHIGH-DOSE MELPHALAN IN PATIENTS WITH MULTIPLE-MYELOMA, Journal of clinical oncology, 15(2), 1997, pp. 660-666
CYTOGENETIC RESPONSE TO LOW-DOSE 5-AZA-2'-DEOXYCYTIDINE (DAC) IN POOR-RISK MYELODYSPLASTIC SYNDROMES (MDS) - PHASE-II STUDY RESULTS
Authors: LUBBERT M HAAK HL KUNZMANN R DANZERDRIESSEN S VERHOEF G MERTELSMANN R WIJERMANS P
Citation: M. Lubbert et al., CYTOGENETIC RESPONSE TO LOW-DOSE 5-AZA-2'-DEOXYCYTIDINE (DAC) IN POOR-RISK MYELODYSPLASTIC SYNDROMES (MDS) - PHASE-II STUDY RESULTS, Blood, 90(10), 1997, pp. 2591-2591
CLINICAL-SIGNIFICANCE OF BCL2 AND P53 PROTEIN EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA - A POPULATION-BASED STUDY
Authors: KRAMER MHH HERMANS J PARKER J KROL ADG KLUINNELEMANS JC HAAK HL VANGRONINGEN K VANKRIEKEN JHJM DEJONG D KLUIN PM
Citation: Mhh. Kramer et al., CLINICAL-SIGNIFICANCE OF BCL2 AND P53 PROTEIN EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA - A POPULATION-BASED STUDY, Journal of clinical oncology, 14(7), 1996, pp. 2131-2138
UNRELATED BONE-MARROW TRANSPLANTATION AS A RESCUE PROCEDURE FOLLOWINGINADVERTENT LOSS OF AN AUTOLOGOUS BONE-MARROW GRAFT
Authors: OUDSHOORN M FALKENBURG JHF EBELING LJ HAAK HL WIJERMANS PW FIBBE WE WILLEMZE R VANROOD JJ
Citation: M. Oudshoorn et al., UNRELATED BONE-MARROW TRANSPLANTATION AS A RESCUE PROCEDURE FOLLOWINGINADVERTENT LOSS OF AN AUTOLOGOUS BONE-MARROW GRAFT, Bone marrow transplantation, 18(2), 1996, pp. 461-463
AN IVS1-116 (A-]G) ACCEPTOR SPLICE-SITE MUTATION IN THE ALPHA(2) GLOBIN GENE CAUSING ALPHA(+) THALASSEMIA IN 2 DUTCH FAMILIES
Authors: HARTEVELD CL HEISTER JGAM GIORDANO PC BATELAAN D VONDELFT P HAAK HL
Citation: Cl. Harteveld et al., AN IVS1-116 (A-]G) ACCEPTOR SPLICE-SITE MUTATION IN THE ALPHA(2) GLOBIN GENE CAUSING ALPHA(+) THALASSEMIA IN 2 DUTCH FAMILIES, British Journal of Haematology, 95(3), 1996, pp. 461-466
STABILITY OF HOMOCYSTEINE IN FULL BLOOD - A COMPARISON OF 6 COLLECTION MEDIA
Authors: WILLEMS HPJ GERRITS WBJ HAAK HL BLOM HJ
Citation: Hpj. Willems et al., STABILITY OF HOMOCYSTEINE IN FULL BLOOD - A COMPARISON OF 6 COLLECTION MEDIA, Blood, 88(10), 1996, pp. 667-667
IS HYPERHOMOCYSTEINAEMIA A RISK FACTOR FOR RECURRENT VENOUS THROMBOSIS
Authors: DENHEIJER M BLOM HJ GERRITS WBJ ROSENDAAL FR HAAK HL WIJERMANS PW BOS GMJ
Citation: M. Denheijer et al., IS HYPERHOMOCYSTEINAEMIA A RISK FACTOR FOR RECURRENT VENOUS THROMBOSIS, Lancet, 345(8954), 1995, pp. 882-885
COMPARISON OF CHOP CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR SLOWLY RESPONDING PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA
Authors: VERDONCK LF VANPUTTEN WLJ HAGENBEEK A SCHOUTEN HC SONNEVELD P VANIMHOFF GW KLUINNELEMANS HC RAEMAEKERS JMM VANOERS RHJ HAAK HL SCHOTS R DEKKER AW DEGAST GC LOWENSBERG B
Citation: Lf. Verdonck et al., COMPARISON OF CHOP CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR SLOWLY RESPONDING PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA, The New England journal of medicine, 332(16), 1995, pp. 1045-1051
LOWERING OF HOMOCYSTEINE BLOOD-LEVELS BY MEANS OF VITAMIN SUPPLEMENTATION
Authors: DENHEIJER M WIJERMANS PW BROUWER LA BOS GMJ BLOM HJ HAAK HL GERRITS WBJ
Citation: M. Denheijer et al., LOWERING OF HOMOCYSTEINE BLOOD-LEVELS BY MEANS OF VITAMIN SUPPLEMENTATION, Blood, 86(10), 1995, pp. 345-345
MYELODYSPLASIA (MDS) AND PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA (PNH) - IS THERE AN ASSOCIATION
Authors: BOS GMJ HAAK HL GERRITS WBJ WIJERMANS P
Citation: Gmj. Bos et al., MYELODYSPLASIA (MDS) AND PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA (PNH) - IS THERE AN ASSOCIATION, Blood, 86(10), 1995, pp. 3150-3150
CYTOGENETIC ANALYSIS OF MULTIPLE-MYELOMA
Authors: HAAK HL WIJERMANS PW VONWEERT J BEVERSTOCK GC
Citation: Hl. Haak et al., CYTOGENETIC ANALYSIS OF MULTIPLE-MYELOMA, Blood, 86(10), 1995, pp. 3322-3322
NEUTROPHIL INCREMENT AFTER SINGLE INJECTION OF CSF
Authors: HAAK HL
Citation: Hl. Haak, NEUTROPHIL INCREMENT AFTER SINGLE INJECTION OF CSF, British Journal of Haematology, 86(2), 1994, pp. 446-446
CONVENTIONAL REMISSION INDUCTION FOLLOWED BY INTENSIVE CONSOLIDATION WITHOUT MAINTENANCE THERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS FROM A PHASE-II CLINICAL-TRIAL IN 130 PATIENTS
Authors: DEKKER AW VANTVEER MB HAAK HL VANDERLELIE J OSSENKOPPELE G SCHOUTEN HC SONNEVELD P VANPUTTEN WLJ WILLEMZE R LOWENBERG B
Citation: Aw. Dekker et al., CONVENTIONAL REMISSION INDUCTION FOLLOWED BY INTENSIVE CONSOLIDATION WITHOUT MAINTENANCE THERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS FROM A PHASE-II CLINICAL-TRIAL IN 130 PATIENTS, Blood, 84(10), 1994, pp. 10000144-10000144
GM-CSF INSTEAD OF AUTOLOGOUS STEM-CELL TRANSPLANTATION AFTER HIGH-DOSE MELPHALAN (HDM) IN MULTIPLE-MYELOMA (MM) - RESULT OF A MULTICENTER RANDOMIZED PLACEBO-CONTROLLED STUDY
Authors: HAROUSSEAU JL FIERE D BEZWODA WR FACON T ATTAL M LAPORTE JP COLOMBAT P HAAK HL MONCONDUIT N LOCKHORST H GIRAULT D
Citation: Jl. Harousseau et al., GM-CSF INSTEAD OF AUTOLOGOUS STEM-CELL TRANSPLANTATION AFTER HIGH-DOSE MELPHALAN (HDM) IN MULTIPLE-MYELOMA (MM) - RESULT OF A MULTICENTER RANDOMIZED PLACEBO-CONTROLLED STUDY, Blood, 84(10), 1994, pp. 10000181-10000181
SEVERE IMMUNODEFICIENCY IN PATIENTS TREATED WITH FLUDARABINE MONOPHOSPHATE
Authors: WIJERMANS PW GERRITS WBJ HAAK HL
Citation: Pw. Wijermans et al., SEVERE IMMUNODEFICIENCY IN PATIENTS TREATED WITH FLUDARABINE MONOPHOSPHATE, European journal of haematology, 50(5), 1993, pp. 292-296
MITOXANTRONE, TENIPOSIDE, CHLORAMBUCIL AND PREDNISONE (MVLP) FOR RELAPSED NON-HODGKINS-LYMPHOMA - THE IMPACT OF ADVANCED AGE AND PERFORMANCE STATUS
Authors: HAAK HL GERRITS WBJ WIJERMANS PW KERKHOFS H
Citation: Hl. Haak et al., MITOXANTRONE, TENIPOSIDE, CHLORAMBUCIL AND PREDNISONE (MVLP) FOR RELAPSED NON-HODGKINS-LYMPHOMA - THE IMPACT OF ADVANCED AGE AND PERFORMANCE STATUS, Netherlands journal of medicine, 42(3-4), 1993, pp. 122-127
DETECTION OF MONOSOMY-7 AND TRISOMY-8 IN MYELOID NEOPLASIA - A COMPARISON OF BANDING AND FLUORESCENCE IN-SITU HYBRIDIZATION
Authors: KIBBELAAR RE MULDER JWR DREEF EJ VANKAMP H FIBBE WE WESSELS JW BEVERSTOCK GC HAAK HL KLUIN PM
Citation: Re. Kibbelaar et al., DETECTION OF MONOSOMY-7 AND TRISOMY-8 IN MYELOID NEOPLASIA - A COMPARISON OF BANDING AND FLUORESCENCE IN-SITU HYBRIDIZATION, Blood, 82(3), 1993, pp. 904-913
Risultati: 1-21 |